Document Detail


The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effects.
MedLine Citation:
PMID:  15465205     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: We investigated the efficacy of hyperbaric oxygen therapy (HBOT) in the management of patients with radiation-induced late side effects, the majority of whom had failed previous interventions. METHODS AND MATERIALS: Of 105 eligible subjects, 30 had either died or were not contactable, leaving 75 who qualified for inclusion in this retrospective study. Patients answered a questionnaire documenting symptom severity before and after treatment (using Radiation Therapy Oncology Group criteria), duration of improvement, relapse incidence, and HBOT-related complications. RESULTS: The rate of participation was 60% (45/75). Improvement of principal presenting symptoms after HBOT was noted in 75% of head-and-neck, 100% of pelvic, and 57% of "other" subjects (median duration of response of 62, 72, and 68 weeks, respectively). Bone and bladder symptoms were most likely to benefit from HBOT (response rate, 81% and 83%, respectively). Fifty percent of subjects with soft tissue necrosis/mucous membrane side effects improved with HBOT. The low response rate of salivary (11%), neurologic (17%), laryngeal (17%), and upper gastrointestinal symptoms (22%) indicates that these were more resistant to HBOT. Relapse incidence was low (22%), and minor HBOT-related complications occurred in 31% of patients. CONCLUSION: Hyperbaric oxygen therapy is a safe and effective treatment modality offering durable relief in the management of radiation-induced osteoradionecrosis either alone or as an adjunctive treatment. Radiation soft tissue necrosis, cystitis, and proctitis also seemed to benefit from HBOT, but the present study did not have sufficient numbers to reliably predict long-term response.
Authors:
Quoc-Chuong Bui; Michael Lieber; H Rodney Withers; Kevan Corson; Marius van Rijnsoever; Hany Elsaleh
Related Documents :
2473515 - Colloid versus crystalloid cardioplegia. a prospective, randomized clinical study.
15995475 - Early administration of hyperbaric oxygen therapy in distraction osteogenesis--a quanti...
24464385 - Postoperative pain after transvaginal cholecystectomy: single-center, double-blind, ran...
24477825 - Difficult airway management for novice physicians: a randomized trial comparing direct ...
19681915 - Severe hyperthyroidism: aetiology, clinical features and treatment outcome.
2498775 - Immunosuppression can arrest progressive renal failure due to idiopathic membranous glo...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of radiation oncology, biology, physics     Volume:  60     ISSN:  0360-3016     ISO Abbreviation:  Int. J. Radiat. Oncol. Biol. Phys.     Publication Date:  2004 Nov 
Date Detail:
Created Date:  2004-10-06     Completed Date:  2004-11-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7603616     Medline TA:  Int J Radiat Oncol Biol Phys     Country:  United States    
Other Details:
Languages:  eng     Pagination:  871-8     Citation Subset:  IM    
Affiliation:
Department of Radiation Oncology, David Geffen School of Medicine at UCLA, 200 Medical Plaza B265, Los Angeles, CA 90095-6951, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Child
Female
Head and Neck Neoplasms / radiotherapy
Humans
Hyperbaric Oxygenation*
Male
Middle Aged
Osteoradionecrosis / therapy
Pelvic Neoplasms / radiotherapy
Radiation Injuries / therapy*
Retrospective Studies
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stereotactic irradiation for intracranial arteriovenous malformation using stereotactic radiosurgery...
Next Document:  Permanent alopecia after cranial irradiation: dose-response relationship.